Ireland
--:--IST
Latest
Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide The €100K Reality Check: Why a Six-Figure Pharma Salary in Ireland Feels Different Than in Switzerland or Germany Ireland's €93.8 Billion Non-EU Pharma Export Engine: Trade Data, Destination Markets, and Economic Impact Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide The €100K Reality Check: Why a Six-Figure Pharma Salary in Ireland Feels Different Than in Switzerland or Germany Ireland's €93.8 Billion Non-EU Pharma Export Engine: Trade Data, Destination Markets, and Economic Impact
Priya Life Science Clinical trial register
TrackersDrugsComparisonsAPI
Trackers› Clinical trials› Montpellier
Clinical trial register · France

Clinical Trials in Montpellier, 2026

Every study on the ClinicalTrials.gov registry that lists a site in France and is open, about to open, active-but-closed, or enrolling by invitation. Filter it, cite it, and take it away as a file.

Download CSV
Source: ClinicalTrials.gov, U.S. National Library of Medicine. Complete coverage — all 9698 matching records held by the registry are in this view. Synced 23 Oct 2026, 03:20 UTC
9698
Studies in scope
all four open statuses
6023
Recruiting now
open to new participants
1034
Lead sponsors
across recruiting studies
Top sites
Paris 38 Lyon 27 Montpellier 21 Marseille 19 Lille 19
Narrow the registerReset
Recruitment status
Phase
Lead sponsor
University Hospital, Montpellier169 AstraZeneca61 Institut du Cancer de Montpellier - Val d'Aurelle59 Novartis Pharmaceuticals32 Hoffmann-La Roche30 Clear sponsor filter
Site location
Paris38 Lyon27 Montpellier21 Marseille19 Lille19
All 66 locations
Target enrolment
to

Trials with a site in Montpellier

21 of 9698 studies
Download
Status
Study
Lead sponsor
Phase
Enrol
Sites in France
Start
Recruiting
Eli Lilly and Company
Phase 2
606
Brest, Cholet, Créteil, La Tronche, Lyon, Marseille, Montpellier, Paris
2026-08-07
Recruiting
Eli Lilly and Company
Phase 2
600
Brest, Montpellier, Plérin, Saint-Cloud, Villejuif
2026-05-13
Recruiting
Eli Lilly and Company
Phase 3
800
Avignon, Besançon, Brest, Clermont-Ferrand, Dijon, Le Mans, Lyon, Montpellier
2025-12-22
Recruiting
Eli Lilly and Company
Phase 3
350
Échirolles, La Roche-sur-Yon, Le Kremlin-Bicêtre, Montpellier, Neuilly-sur-Seine, Nice, Paris, Saint-Priest-en-Jarez
2025-06-26
Recruiting
Eli Lilly and Company
Phase 3
290
Échirolles, La Roche-sur-Yon, Le Kremlin-Bicêtre, Montpellier, Neuilly-sur-Seine, Nice, Paris, Rouen
2025-06-26
Active, closed
Eli Lilly and Company
Phase 3
905
Caen, Corbeil-Essonnes, Le Creusot, Lyon, Marseille, Montpellier, Nantes, Pontoise
2025-04-25
Active, closed
Eli Lilly and Company
Phase 3
10,000
Bois-Guillaume, Bordeaux, Clermont-Ferrand, Corbeil-Essonnes, La Tronche, Le Coudray, Montpellier, Nantes
2024-04-30
Active, closed
Eli Lilly and Company
Phase 3
925
Lyon, Brest, La Chaussée-Saint-Victor, Dijon, Besançon, Montpellier, Nantes, Saint-Herblain
2022-04-14
Active, closed
Eli Lilly and Company
Phase 3
874
Strasbourg, La Chaussée-Saint-Victor, Besançon, Saint-Cloud, Montpellier, Le Mans, Bayonne, Paris
2021-10-04
Active, closed
Study of LY3537982 in Cancer Patients With a Specific Genetic Mutation (KRAS G12C)
NCT04956640Carcinoma, Non-Small-Cell Lung, Colorectal Neoplasms, Endometrial Neoplasms, Ovarian Neoplasms
DrugsOlomorasib·Erbitux·Cetuximab·Pemetrexed
Eli Lilly and Company
Phase 1/2
540
Bordeaux, Lyon, Montpellier, Toulouse, Villejuif
2021-07-19
Active, closed
Eli Lilly and Company
Phase 3
101
Bron, Montpellier, Le Kremlin-Bicêtre, Poitiers, Paris
2021-04-13
Active, closed
Eli Lilly and Company
Phase 3
996
Montpellier, Vandœuvre-lès-Nancy, Poitiers
2020-06-22
Active, closed
Eli Lilly and Company
Phase 3
261
Lyon, Marseille, Montpellier, La Tronche, Clermont-Ferrand, Paris
2020-02-17
Active, closed
Eli Lilly and Company
Phase 2/3
393
Lyon, Montpellier, Le Mans, La Roche-sur-Yon, Bordeaux, Créteil
2018-11-26
Active, closed
Eli Lilly and Company
Phase 3
1,058
Amiens, Chambray-lès-Tours, Lille, Montpellier, Neuilly-sur-Seine, Nice, Paris, Pau
2018-07-18
Active, closed
Eli Lilly and Company
Phase 3
5,637
Lyon, Brest, La Chaussée-Saint-Victor, Dijon, Plérin, Besançon, Rennes, Montpellier
2017-07-12
Active, closed
Eli Lilly and Company
Phase 1/2
857
Bordeaux, Lyon, Marseille, Montpellier, Villejuif, Paris
2017-05-02
Active, closed
Eli Lilly and Company
Phase 1
100
Lille, Montpellier, Toulouse
2016-11-14
Active, closed
Eli Lilly and Company
Phase 2
309
Lyon, Bordeaux, Besançon, Lille, Montpellier, Nice, Villejuif
2016-05-19
Active, closed
Eli Lilly and Company
Phase 3
545
Montpellier, La Tronche, Lille, Poitiers, Paris
2015-05-06
Active, closed
Eli Lilly and Company
Phase 3
493
Bordeaux, Lyon, Brest, Dijon, Saint-Brieuc, Montpellier, Saint-Herblain, Nancy
2014-11-06
Rows per page Showing 1–21 of 21
1
Cite this view

Priya Life Science (2026). Clinical trial register: studies with a French investigative site, filtered. Derived from ClinicalTrials.gov. Retrieved 25 October 2026. https://priyalifescience.com/clinical-trials-france/city/montpellier

Query this register directly
GET /api/trials?country=in&status=recruiting&format=json Try it now →

About this register

This register is built from ClinicalTrials.gov, the trial registry run by the U.S. National Library of Medicine. It includes every study on the registry that lists at least one investigative site in France and is recruiting, not yet recruiting, active but no longer recruiting, or enrolling by invitation: 9,698 studies in total at the last sync on 23 Oct 2026, 03:20 UTC. The full list can be downloaded as CSV or queried as JSON through the register API.

This page shows the 21 of those studies with a site in Montpellier that also match the filters currently applied.

How many clinical trials are recruiting in Montpellier?

5 of the 21 studies on this page are recruiting new participants as of the 23 Oct 2026, 03:20 UTC sync. A further 0 have not yet opened recruitment, 16 are active but closed to new participants, and 0 are enrolling by invitation only. Eligibility for any study is decided by its study team.

Summary by phase

Studies by phase (Montpellier), 21 studies
PhaseStudiesRecruitingShare
Phase 314366.7%
Phase 23214.3%
Phase 1/2209.5%
Phase 1104.8%
Phase 2/3104.8%

Most active sponsors

Lead sponsors with the most studies (Montpellier)
Lead sponsorStudiesRecruiting
Eli Lilly and Company215
Listing here is informational and not medical advice; eligibility is determined by each study team. See also the Ireland, UK, EU, USA and China registers.